Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts in category Stock Picks

ITC: Stellar 26% YTD Return Makes It A Hold



ITC’s spectacular 26% YTD return makes it a strong defensive stock to HOLD says J. P. Morgan

Brokerages recommend four stocks for investment



Brokerages recommend four stocks for investment

What went wrong with Suzlon Energy?



What went wrong with Suzlon Energy?

Moneycontrol.com has a superb article on why Suzlon, which was a promising star in the horizon, is now on the verge of bankrupcy

South Indian Bank 1QF13: Result Review



South Indian Bank 1QF13: Result Review

SBICaps brings to you the attached 1QF13 South Indian Bank result provided by its Research Team for your perusal

Best Pharma Stocks To Buy



SBICaps brings to you the attached 1QF13 result preview on India Pharma provided by its Research Team for your perusal

Engineers India Ltd – Visit Note



Engineers India Ltd – Visit Note

SBICaps brings to you the attached Visit Note Report on Engineers India Ltd provided by its Research Team for your perusal

Ajanta Pharma 1QF13: Result Review



SBICaps brings to you the attached Initiating Coverage Report on Navneet Publications (India) Ltd provided by its Research Team for your perusal

Buy Maruti Suzuki Below Rs. 1,000: Raamdeo Agrawal



Raamdeo Agrawal suggests that Maruti Suzuki’s problems are temporary and one should buy the stock

Buy Navneet Publications: SBICaps



SBICaps brings to you the attached Initiating Coverage Report on Navneet Publications (India) Ltd provided by its Research Team for your perusal

Best Oil & Gas Stocks To Buy



SBICaps brings to you the attached Monthly Review – June 2012 of the Oil & Gas sector provided by its Research Team for your perusal

← Older Entries Newer Entries →

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 509 other subscribers

RSS Stocks Talk Forum

  • Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside)
    Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China rebalancing drive by global innovators likely to continue. Other growth levers are intact. Buy for TP ₹320 (27% upside) Download report... Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 […]
  • The "Golden Crossover" strategy signals a Bullish trend is underway & yields multibagger returns
    Expert says the "Golden Crossover" strategy, where the 50 DMA crosses above the 200 DMA, signals that a Bullish trend is underway. It yields multibagger returns. Top investors & traders use this. There are scanners which reveal when crossover is happening ET's screener shows stocks which have undergone the "golden crossover" in the recent past. […]
  • Hiren Ved has no Banking stocks in his portfolio.
    Hiren Ved has no Bank stocks in his portfolio because Banks are unable to get cheap deposits & lend profitably. People are investing in SIPs instead of FDs & Capital Market stocks are better than Bank stocks. HDFC AMC is a better investment than HDFC Bank [youtube https://www.youtube.com/watch?v=O4SA4czZqY0]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!